Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 6—June 2011


Cefepime-Resistant Pseudomonas aeruginosa

Ehimare Akhabue, Marie Synnestvedt, Mark G. Weiner, Warren B. Bilker, and Ebbing LautenbachComments to Author 
Author affiliations: Author affiliation: University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Main Article

Table 3

Multivariable model of association between infection with cefepime-resistant Pseudomonas aeruginosa and death, Philadelphia, PA, USA, 2001–2006*

Variable Adjusted OR (95% CI) p value
Cefepime-resistant organism 1.28 (0.86–1.90) 0.232
Patient in ICU at time of culture 2.33 (1.75–3.10) <0.001
APR-DRG 11.29 (6.53–19.50) <0.001
Patient transfer from outside hospital 1.38 (1.05–1.81) 0.021
Length of hospital stay before culture 0.99 (0.98–1.00) 0.231

*OR, odds ratio; CI, confidence interval; ICU, intensive care unit; APR-DRG, all-patient refined-diagnosis–related group.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO